Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.963%),Abigail P. Johnson(12.963%)
Spyre Therapeutics | 4:持股变动声明-董事 Stelzer Laurie
Spyre Therapeutics | 4:持股变动声明-董事 Albers Jeffrey W.
Spyre Therapeutics | 4:持股变动声明-董事 Milligan Sandra
Spyre Therapeutics | 4:持股变动声明-董事 Fairmount Funds Management LLC
Spyre Therapeutics | 4:持股变动声明-董事 HENDERSON MICHAEL THOMAS
Spyre Therapeutics | 3:首次持股声明-董事 Milligan Sandra
Spyre Therapeutics | 4:持股变动声明-董事 Fairmount Funds Management LLC
Spyre Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Peter Harwin(11.17%),Tomas Kiselak(11.17%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(5.1%),Behzad Aghazadeh(5.1%)
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(18.213%),Abigail P. Johnson(18.213%)
Spyre Therapeutics | 4:持股变动声明-高管 Turtle Cameron
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(5.4%),Commodore Capital Master LP(5.4%)
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(0.0%),Baker Bros. Advisors (GP) LLC(0.0%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(2.5%),Oleg Nodelman(2.5%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(0%),Wilmot B. Harkey(0%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(7.2%),Joseph Edelman(7.2%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Logos Global Management LP(0.4%),Logos Global Management GP LLC(0.4%)等
Spyre Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rock Springs Capital Management LP(0%),Rock Springs Capital LLC(0%)
暂无数据